Russell Investments Group, Ltd. Fulcrum Therapeutics, Inc. Transaction History
Russell Investments Group, Ltd.
- $66.8 Billion
- Q3 2024
A detailed history of Russell Investments Group, Ltd. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 47 shares of FULC stock, worth $156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47Holding current value
$156% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding FULC
# of Institutions
147Shares Held
52.1MCall Options Held
6.83MPut Options Held
1.83M-
Ra Capital Management, L.P. Boston, MA10.2MShares$34 Million0.51% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$17.4 Million2.43% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$15.9 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$15.9 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$10.9 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $173M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...